Dr William Makis has been ahead of the curve in understanding and treating turbo cancers

“The bad news is that he continues to see so many young people with stage 4 cancers. In particular young women in their 20s and 30s presenting with stage 4 breast cancer. Something he has never seen before. The good news is that he has had success in treating them with repurposed drugs ie. ivermectin and fenbendazole. These are drugs which are extremely safe and should be available over the counter in western countries!”

(8) Kat A 🌸 on X: “Dr William Makis has been ahead of the curve in understanding and treating turbo cancers. The bad news is that he continues to see so many young people with stage 4 cancers. In particular young women in their 20s and 30s presenting with stage 4 breast cancer. Something he has https://t.co/nYbCSRHG45” / X

Published by markskidmore

Mark Skidmore is Professor of Economics at Michigan State University where he holds the Morris Chair in State and Local Government Finance and Policy. His research focuses on topics in public finance, regional economics, and the economics of natural disasters. Mark created the Lighthouse Economics website and blog to share economic research and information relevant for navigating tumultuous times.

Leave a Reply

Discover more from Lighthouse Economics

Subscribe now to keep reading and get access to the full archive.

Continue reading